Bradley Catalone
About Bradley Catalone
Bradley Catalone serves as the Head of Drug Development at Verrica Pharmaceuticals, bringing extensive experience in pharmaceuticals and medical devices. His career includes leadership roles at various companies, emphasizing research, development, and laboratory management.
Current Role at Verrica Pharmaceuticals
Bradley Catalone serves as the Head of Drug Development at Verrica Pharmaceuticals, a position he has held since 2020. In this role, he oversees the drug development process, ensuring that projects align with the company's strategic objectives. His leadership contributes to advancing Verrica's portfolio in the pharmaceutical industry, particularly in the development of innovative treatments.
Previous Experience in Clinical Affairs
Prior to his current role, Bradley Catalone held significant positions in various organizations. He worked at Olympus as the Director of Clinical Affairs from 2009 to 2011 and as Director of Research from 2004 to 2010. His experience at Olympus involved overseeing clinical operations and research initiatives, contributing to the advancement of medical technologies.
Educational Background
Bradley Catalone has an extensive educational background. He earned a Master of Arts in Biology from Villanova University from 1995 to 1998. He then pursued a PhD in Microbiology and Immunology at Pennsylvania State University College of Medicine from 1998 to 2003. Additionally, he obtained a Master of Business Administration (MBA) in Business Administration and Management from Penn State University from 1999 to 2003. He also holds a Bachelor of Arts in Biology from Franklin & Marshall College, completed from 1990 to 1992.
Expertise in Laboratory Operations
Bradley Catalone has developed a strong expertise in laboratory operations throughout his career. He served as Vice President of Laboratory Operations at Alcami Corporation from 2016 to 2017 and as Senior Director of Laboratory Operations from 2015 to 2016. His roles involved managing laboratory processes and implementing improvements to enhance operational efficiency.
Diverse Background in Pharmaceuticals and Medical Devices
Bradley Catalone possesses a diverse background in pharmaceuticals, medical devices, and consumer products. His career includes roles such as Chief Science Officer at TSO3 from 2017 to 2019 and Senior Scientific Advisor at Healthmark Industries from 2019 to 2020. This varied experience has equipped him with a comprehensive understanding of research and development in these sectors.